News from the FDA/CDC
News from the FDA/CDC
Most pregnancy-related deaths are preventable
Almost one-third of pregnancy-related deaths occur before delivery, the CDC reported.
Commentary
Powerful breast-implant testimony constrained by limited evidence
SILVER SPRING, MD. – Women report personal horror stories of apparent breast-implant complications, but systematically-collected data remain...
Conference Coverage
FDA panel calls for changes to breast implant rupture screening
The advisory panel seemed the current implant screening recommendation using MRI “useless.” They urged the adoption of ultrasound as a more...
News
FDA approves Tecentriq plus Abraxane in breast cancer
The immunotherapy regimen received accelerated approval for the treatment of PD-L1-positive triple-negative breast cancer in adults.
News
FDA: 246 new reports on breast implant-associated lymphoma
The latest update from the Food and Drug Administration includes medical device reports between September 2017 and September 2018.
News
FDA approves third trastuzumab biosimilar
The drug is approved for treatment of HER2-overexpressing breast cancer and HER2-overexpressing metastatic gastric or gastroesophageal junction...
News from the FDA/CDC
Infant mortality generally unchanged in 2016
Infant mortality by maternal age was similar for women aged 20-24 years and those aged 40 years and over.
News from the FDA/CDC
Abortion measures continue to fall
The total number of abortions, along with the rate and ratio, declined steadily from 2006 to 2015.
News from the FDA/CDC
Endocrine Society raises concerns about FDA’s “safe” classification of bisphenol A in food containers
Results from the CLARITY-BPA Core Study show serious effects in humans of bisphenol A at low doses, despite claims from the FDA.
Latest News
Drug overdose deaths down since late 2017
Longer-term trend, however, shows an increase of 2.7% during the 12 months ending in March 2018, compared with March 2017.
News
Talazoparib approved for HER2-negative advanced breast cancer
The